These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25231121)

  • 1. Disordered structural ensembles of vasopressin and oxytocin and their mutants.
    Yedvabny E; Nerenberg PS; So C; Head-Gordon T
    J Phys Chem B; 2015 Jan; 119(3):896-905. PubMed ID: 25231121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of oxytocin with Ca2+: I. CD and fluorescence spectral characterization and comparison with vasopressin.
    Ananthanarayanan VS; Brimble KS
    Biopolymers; 1996; 40(5):433-43. PubMed ID: 9062067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A vasopressin/oxytocin-related conopeptide with gamma-carboxyglutamate at position 8.
    Möller C; Marí F
    Biochem J; 2007 Jun; 404(3):413-9. PubMed ID: 17331075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trafficking of the vasopressin and oxytocin prohormone through the regulated secretory pathway.
    de Bree FM
    J Neuroendocrinol; 2000 Jun; 12(6):589-94. PubMed ID: 10844588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron capture dissociation of peptide hormone changes upon opening of the tocin ring and complexation with transition metal cations.
    van der Burgt YE; Palmblad M; Dalebout H; Heeren RM; Deelder AM
    Rapid Commun Mass Spectrom; 2009 Jan; 23(1):31-8. PubMed ID: 19051230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and expression of two oxytocin/vasopressin-related peptides in the cuttlefish Sepia officinalis.
    Henry J; Cornet V; Bernay B; Zatylny-Gaudin C
    Peptides; 2013 Aug; 46():159-66. PubMed ID: 23764263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosinate fluorescence lifetimes for oxytocin and vasopressin in receptor-simulating environments: relationship to biological activity and 1H-NMR data.
    Turner RJ; Matsoukas JM; Moore GJ
    Biochem Biophys Res Commun; 1990 Sep; 171(3):996-1001. PubMed ID: 2171514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of an unliganded neurophysin and its vasopressin complex: implications for binding and allosteric mechanisms.
    Wu CK; Hu B; Rose JP; Liu ZJ; Nguyen TL; Zheng C; Breslow E; Wang BC
    Protein Sci; 2001 Sep; 10(9):1869-80. PubMed ID: 11514677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contributions of oxytocin and vasopressin pathway genes to human behavior.
    Ebstein RP; Knafo A; Mankuta D; Chew SH; Lai PS
    Horm Behav; 2012 Mar; 61(3):359-79. PubMed ID: 22245314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quo vadis neurohypophysial hormone research?
    Douglas AJ; Ludwig M
    Exp Physiol; 2000 Mar; 85 Spec No():267S-272S. PubMed ID: 10795931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitory coexistence of oxytocin and vasopressin in the hypothalamo neurohypophysial system of parturient rats.
    Jirikowski GF; Ramalho-Ortigao FJ; Caldwell JD
    Horm Metab Res; 1991 Oct; 23(10):476-80. PubMed ID: 1761278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics study of the internal water molecules in vasopressin and oxytocin receptors.
    Slusarz MJ; Slusarz R; Ciarkowski J
    Protein Pept Lett; 2009; 16(4):342-50. PubMed ID: 19356129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New opportunities in vasopressin and oxytocin research: a perspective from the amygdala.
    Stoop R; Hegoburu C; van den Burg E
    Annu Rev Neurosci; 2015 Jul; 38():369-88. PubMed ID: 26154981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel vasopressin/oxytocin superfamily peptide and its receptor from an ascidian, Ciona intestinalis.
    Kawada T; Sekiguchi T; Itoh Y; Ogasawara M; Satake H
    Peptides; 2008 Oct; 29(10):1672-8. PubMed ID: 18586058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system.
    Slusarz MJ; Slusarz R; Ciarkowski J
    Biopolymers; 2006 Apr; 81(5):321-38. PubMed ID: 16333859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular evolution of the neurohypophysial hormone precursors in mammals: Comparative genomics reveals novel mammalian oxytocin and vasopressin analogues.
    Wallis M
    Gen Comp Endocrinol; 2012 Nov; 179(2):313-8. PubMed ID: 22995712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of vasopressin, oxytocin, and their analogues in the human gastrointestinal tract.
    Fjellestad-Paulsen A; Söderberg-Ahlm C; Lundin S
    Peptides; 1995; 16(6):1141-7. PubMed ID: 8532599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single exon structures of the oxytocin/vasopressin superfamily peptides of octopus.
    Kanda A; Takuwa-Kuroda K; Iwakoshi-Ukena E; Minakata H
    Biochem Biophys Res Commun; 2003 Oct; 309(4):743-8. PubMed ID: 13679034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salt-dependent structural changes of neurohormones: lithium ions induce conformational rearrangements of ocytocin to a vasopressin-like structure.
    Rholam M; Nicolas P; Cohen P
    Biochemistry; 1985 Jun; 24(13):3345-9. PubMed ID: 2992581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.